hit counter
Conformis, Inc. (CFMS) Stock News Sentiment & Price - Sentifly
CFMS - Sentifly


Profile

Watchlist

Your watchlist is empty. Go add some tickers to it!



Conformis, Inc. (CFMS)

USA
Medical Instruments & Supplies
NASDAQ
CFMS Price and Sentiment
1MO
1D
Positive, Negative
Loading chart...
CFMS Latest news
GlobeNewsWire
Neutral
Conformis, Inc. Appoints James Paiva as its new Vice President of U.S. Marketing; Inducement Grant Reported
2021-11-08 09:00

BILLERICA, Mass., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that the Company has appointed James Paiva as its new Vice President, U.S. Marketing.

Seeking Alpha
Neutral
Conformis, Inc. (CFMS) CEO Mark Augusti on Q3 2021 Results - Earnings Call Transcript
2021-11-03 20:10

Conformis, Inc. (CFMS) CEO Mark Augusti on Q3 2021 Results - Earnings Call Transcript

Zacks Investment Research
Positive
ConforMIS (CFMS) Reports Q3 Loss, Tops Revenue Estimates
2021-11-03 19:53

ConforMIS (CFMS) delivered earnings and revenue surprises of 0.00% and 1.24%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

GlobeNewsWire
Neutral
Conformis Reports Third Quarter 2021 Financial Results
2021-11-03 16:05

BILLERICA, Mass., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today financial results for the third quarter ended September 30, 2021.

Zacks Investment Research
Negative
ConforMIS (CFMS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
2021-10-27 16:11

ConforMIS (CFMS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research
Positive
Conformis (CFMS) to Post Q3 Earnings: What's in the Offing?
2021-10-26 11:51

Conformis' (CFMS) third-quarter results are likely to reflect strength in core products.

GlobeNewsWire
Neutral
Conformis, Inc. to Release Third Quarter 2021 Financial Results on November 3, 2021
2021-10-04 17:00

BILLERICA, Mass., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today that it will release its financial results for the third quarter ended September 30, 2021 after the market closes on November 3, 2021 at approximately 4:00 p.m. Eastern Time.

Zacks Investment Research
Negative
Conformis (CFMS) Sees Hammer Chart Pattern: Time to Buy?
2021-10-04 08:45

Conformis (CFMS) has been struggling lately, but the selling pressure may be coming to an end soon.

Benzinga
Positive
Conformis Posts Clinical Study Data For Its Knee Implants
2021-09-30 09:24

Conformis Inc (NASDAQ: CFMS) announced results of a published retrospective study of procedures using Conformis' patient-specific iTotal CR (cruciate-retaining) knee replacement implant. Data showed that implant survivorship was 98.5% with 8 revisions (representing 1.5% of the 540 implants reviewed) at a mean follow-up of 2.8 years.

GlobeNewsWire
Neutral
Conformis, Inc. Announces Strong Clinical Study Results for Its Personalized Knee Implants
2021-09-29 17:00

A retrospective review of 540 procedures performed demonstrated 98.5% Implant Survivorship and 89.0% Patient Satisfaction for the Conformis patient-specific iTotal® CR (cruciate-retaining) knee replacement implants at mid-term follow-up A retrospective review of 540 procedures performed demonstrated 98.5% Implant Survivorship and 89.0% Patient Satisfaction for the Conformis patient-specific iTotal® CR (cruciate-retaining) knee replacement implants at mid-term follow-up

Loading more news...